Elemer Piros on the Potential of Psychedelics
Elemer Piros, Managing Director & Senior Research Analyst at Roth Capital Markets, speaks about the expanding psychedelics market. …
Elemer Piros, Managing Director & Senior Research Analyst at Roth Capital Markets, speaks about the expanding psychedelics market.
According to Piros, psychedelic clinic research is in an explosive phase. They are seeing confirmation of previous academic work, but this time done properly, with controls.
"The potential is there to actually revolutionize mental health care - depression, PTSD, anxiety, eating disorders and substance abuse," says Piros. The remission rates are double to triple in comparison to placebo or standard of care. "These kinds of results are unheard of in the history of mental health care."
Latest Articles
Hot Companies
You might also like
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.
BTV Visits Atlas Salt, Graphene Manufacturing, Telescope Innovations, Nevada Organic Phosphate, Maple Gold, Intrepid Metals and Nine Mile Metals
As the resource cycle accelerates, BTV – Business Television highlights companies turning exploration, innovation and strategic growth into actionable opportunity.
